Author: Yue Qi
A webinar hosted by CRASH-4 on the benefits of intramuscular TXA administration
On 10th September 2024, the CRASH-4 trial’s Chief Investigator delivered a pivotal webinar on the administration of intramuscular tranexamic acid (IM-TXA) in emergency medicine. The session highlighted key lessons and recommendations drawn from the Manchester Arena Bombing inquiry, which emphasized the critical role of timely IM-TXA administration in trauma care, especially in mass casualty situations.
Details
A patient’s perspective in CRASH-4
We are incredibly fortunate to hear directly from a CRASH-4 trial participant as they share their personal journey of being enrolled in the study. In this video, they recount their experience, highlighting the meticulous care and support they received from the dedicated team at Dorset County Hospital. Their story offers a unique and heartfelt perspective
Details